Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
We compare Which Dividend Aristocrats Etf Did Best In 2024, spotlighting performance leaders and factors behind stronger returns.
23,010 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
New York Governor Hochul’s decision to pause autonomous for-hire vehicle expansion outside NYC hits Waymo and Tesla’s...
November 2025 marks a new milestone as the Bitcoin Lightning Network surpasses $1B in monthly volume, signaling a shi...
XRP traders are watching a ripple price alert: last signal that historically preceded a major rally. Analysts caution...
A major fund slashed its stake in Papa John's, triggering questions about the stock's outlook. This guide explains wh...
Backpack is launching a year-long staking program that could convert a portion of its tokens into a 20% equity stake ...
Stanley Martin Homes will acquire United Homes Group in an all-cash deal valued at $221 million, taking UHG private a...
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Brisk advances in speed, stealth, and digital systems are forcing defense forces to overhaul how pilots are trained, ...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
As markets enter 2026, a century of stock market data underpins a new wave of strategy. This piece distills three les...
A 2.8% cost-of-living bump boosts checks in January, but higher Medicare costs and a government scheduling overhaul m...